Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(14):943; doi:10.1093/jnci/djj311
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2006.

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Nutritional Interventions and Cancer or Preinvasive Lesions

Dietary modifications and supplements are used widely as an adjunct to standard treatment by patients with cancer or preinvasive lesions. Davies et al. (p. 961) conducted a review of randomized controlled trials of nutritional interventions to examine benefits and harms in such patients. They identified 59 eligible trials; trial quality was generally low. Mortality, cancer recurrence, and other outcomes were not associated with weight loss, exercise, or a healthy diet—alone or with dietary supplements. There was thus no evidence that dietary changes by cancer patients improve survival or benefit disease prognosis.

There is also little . . . [Full Text of this Article]

Gene Promoter Methylation and Bladder Cancer Detection

Connective Tissue Growth Factor and Angiogenesis

DDT, DDE, and liver cancer

Hormone Receptor Status of Mouse Mammary Stem Cells

STK15 F31I Polymorphism and Breast Cancer Risk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?